Katharina Engel, Martina Rudelius, Jolanta Slawska, Laura Jacobs, Behnaz Abhari, Bettina Altmann, Julia Kurutz, Abirami Rathakrishnan, Vanesa Fernández-Sáiz, Andrä Brunner, Bianca-Sabrina Targosz, Felicia Loewecke, Christian Gloeckner, Marius Ueffing, Simone Fulda, Michael Pfreundschuh, Lorenz Trümper, Wolfram Klapper, Ulrich Keller, Philipp J. Jost, Andreas Rosenwald, Christian Peschel, Florian Bassermann
- The mitotic spindle assembly checkpoint (SAC) maintains genome stability and marks an important target for antineoplastic therapies. However, it has remained unclear how cells execute cell fate decisions under conditions of SAC‐induced mitotic arrest. Here, we identify USP9X as the mitotic deubiquitinase of the X‐linked inhibitor of apoptosis protein (XIAP) and demonstrate that deubiquitylation and stabilization of XIAP by USP9X lead to increased resistance toward mitotic spindle poisons. We find that primary human aggressive B‐cell lymphoma samples exhibit high USP9X expression that correlate with XIAP overexpression. We show that high USP9X/XIAP expression is associated with shorter event‐free survival in patients treated with spindle poison‐containing chemotherapy. Accordingly, aggressive B‐cell lymphoma lines with USP9X and associated XIAP overexpression exhibit increased chemoresistance, reversed by specific inhibition of either USP9X or XIAP. Moreover, knockdown of USP9X or XIAP significantly delays lymphoma development and increases sensitivity to spindle poisons in a murine Eμ‐Myc lymphoma model. Together, we specify the USP9X–XIAP axis as a regulator of the mitotic cell fate decision and propose that USP9X and XIAP are potential prognostic biomarkers and therapeutic targets in aggressive B‐cell lymphoma.
MetadatenAuthor: | Katharina Engel, Martina Rudelius, Jolanta Slawska, Laura Jacobs, Behnaz Abhari, Bettina Altmann, Julia Kurutz, Abirami Rathakrishnan, Vanesa Fernández-Sáiz, Andrä Brunner, Bianca-Sabrina Targosz, Felicia Loewecke, Christian Gloeckner, Marius Ueffing, Simone FuldaORCiDGND, Michael Pfreundschuh, Lorenz TrümperORCiDGND, Wolfram KlapperORCiDGND, Ulrich KellerORCiDGND, Philipp J. Jost, Andreas RosenwaldGND, Christian Peschel, Florian BassermannORCiDGND |
---|
URN: | urn:nbn:de:hebis:30:3-505009 |
---|
DOI: | https://doi.org/10.15252/emmm.201506047 |
---|
ISSN: | 1757-4684 |
---|
ISSN: | 1715-4684 |
---|
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/27317434 |
---|
Parent Title (English): | EMBO molecular medicine |
---|
Publisher: | Wiley-VCH ; MBO Press |
---|
Place of publication: | Weinheim ; Heidelberg |
---|
Document Type: | Article |
---|
Language: | English |
---|
Year of Completion: | 2016 |
---|
Date of first Publication: | 2016/06/17 |
---|
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Release Date: | 2019/07/25 |
---|
Tag: | B-cell lymphoma; USP9X; XIAP; mitosis; ubiquitin |
---|
Volume: | 8 |
---|
Issue: | 8 |
---|
Page Number: | 12 |
---|
First Page: | 851 |
---|
Last Page: | 862 |
---|
Note: | © 2016 The Authors. Published under the terms of the CC BY 4.0 license |
---|
HeBIS-PPN: | 452211867 |
---|
Institutes: | Medizin / Medizin |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Licence (German): | Creative Commons - Namensnennung 4.0 |
---|